{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-033912","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2022-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.465027+00:00","generated_at":"2026-06-26T22:42:53.230544+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Esperion CFO Richard Bartram to step down effective April 8, 2022","bullets":["CFO, Principal Financial Officer and Principal Accounting Officer Richard B. Bartram departing.","Departure effective April 8, 2022; no successor named in filing.","Decision not due to any disagreement with company operations, policies or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-033912","json":"https://secwatch.observer/filing/0001104659-22-033912.json","markdown":"https://secwatch.observer/filing/0001104659-22-033912.md","text":"https://secwatch.observer/filing/0001104659-22-033912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/0001104659-22-033912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/tm229356d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T22:42:53.230544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d28f1ee06b","claim":"Richard B. Bartram departed as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer at Esperion Therapeutics, Inc..","evidence_excerpt":"On March 15, 2022, Esperion Therapeutics, Inc. (the “Company”) announced that Richard B. Bartram was stepping down from his positions as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective as of April 8, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/0001104659-22-033912-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepping down"},{"label":"Role","value":"Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}